|
Reference #:
2003-138
Inventors/Contributors
Alan P. Fields, Ph.D.
Description
Transgenic mice expressing levels of PKCbetaII in the colonic epithelium can be used as a model to assess the efficacy of a novel PPARgamma ligand as a chemopreventive and chemotherapeutic agent against colon cancer. These mice are highly susceptible to carcinogen-induced colon cancer.
Patent Status
None |
|
Contact
Susan L. Stoddard, Ph.D., Licensing Manager
sstoddard@mayo.edu
|
|
Mayo Foundation for Medical Education and Research
Office of Technology Commercialization
Centerplace 4
200 First Street SW
Rochester, MN 55905
|
Phone: (507) 284-1222
Fax: (507) 284-5410
|
|
|
